SECsense Logo

Traws Pharma, Inc. 8-K Filing Report: Key Insights and Updates

$TRAW
Form 8-K
Filed on: 2025-02-19
Source
Traws Pharma, Inc. 8-K Filing Report: Key Insights and Updates

The provided XML section from a financial report contains key details regarding Traws Pharma, Inc. Here are the important insights extracted:

  1. Entity Information:
  • Company Name: Traws Pharma, Inc.
  • CIK: 0001130598
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-36020
  • Employer Identification Number (EIN): 22-3627252
  • Address: 12 Penns Trail, Newtown, PA 18940
  • Phone Number: 267-759-3680
  1. Filing Information:
  • Form Type: 8-K (used for reporting unscheduled material events or corporate changes)
  • Filing Date: February 18, 2025
  1. Stock Information:
  • Common Stock: Par value of $0.01 per share
  • Ticker Symbol: TRAW
  • Exchange: NASDAQ
  1. Reporting Period:
  • Period Start Date: February 18, 2025
  • Period End Date: February 18, 2025
  1. Financial Reporting Units:
  • Currency: USD (U.S. Dollars)
  • Shares: The report mentions shares in the context of stock.

Summary:

The report indicates that Traws Pharma, Inc. filed an 8-K on February 18, 2025, which is relevant for stakeholders to monitor material events. The company is incorporated in Delaware and trades under the ticker TRAW on the NASDAQ with a par value of common stock at $0.01 per share. The context suggests a specific reporting event on the same date, indicating possible significant developments or disclosures by the company.